Search Results - "HOXHA, Ariela"

Antiphospholipid antibody profile based obstetric outcomes of primary antiphospholipid syndrome: the PREGNANTS study by Saccone, Gabriele, MD, Berghella, Vincenzo, MD, Maruotti, Giuseppe Maria, MD, Ghi, Tullio, MD, Rizzo, Giuseppe, MD, Simonazzi, Giuliana, MD, Rizzo, Nicola, MD, Facchinetti, Fabio, MD, Dall’Asta, Andrea, MD, Visentin, Silvia, MD, Sarno, Laura, MD, Xodo, Serena, MD, Bernabini, Dalila, MD, Monari, Francesca, MD, Roman, Amanda, MD, Eke, Ahizechukwu Chigoziem, MD, Hoxha, Ariela, MD, Ruffatti, Amelia, MD, Schuit, Ewoud, MD, Martinelli, Pasquale, MD

“…Background Antiphospholipid syndrome is an autoimmune, hypercoagulable state that is caused by antiphospholipid antibodies. Anticardiolipin antibodies, anti-β2…”
Get full text

Editorial: Women in obstetric and pediatric pharmacology: 2023 by Hoxha, Ariela, Mainini, Nicoletta, Visentin, Silvia

Get full text

Treatment of Refractory/High-Risk Pregnancies With Antiphospholipid Syndrome: A Systematic Review of the Literature by Hoxha, Ariela, Tormene, Daniela, Campello, Elena, Simioni, Paolo

“…Different treatment protocols have been employed to manage heparin/low-dose aspirin refractory or high-risk pregnancies in antiphospholipid antibody syndrome…”
Get full text

COVID-19 vaccine and the risk of flares in inflammatory arthritis: a systematic literature review and meta-analysis by Hoxha, Ariela, Striani, Giovanni, Lovisotto, Marco, Simioni, Paolo, Doria, Andrea, Ramonda, Roberta

“…Introduction Coronavirus disease 2019 (COVID-19) vaccines aroused concerns about the risk of flares and adverse events in inflammatory arthritis (IA) since the…”
Get full text

Antiphosphatidylserine/prothrombin antibodies as biomarkers to identify severe primary antiphospholipid syndrome by Hoxha, Ariela, Mattia, Elena, Tonello, Marta, Grava, Chiara, Pengo, Vittorio, Ruffatti, Amelia

“…Anti-phosphatidylserine/prothrombin (aPS/PT) antibodies have begun to be considered potentional biomarkers for antiphospholipid syndrome (APS). This cohort…”
Get more information

Detection of IgG anti-Domain I beta2 Glycoprotein I antibodies by chemiluminescence immunoassay in primary antiphospholipid syndrome by Meneghel, Lauro, Ruffatti, Amelia, Gavasso, Sabrina, Tonello, Marta, Mattia, Elena, Spiezia, Luca, Tormene, Daniela, Hoxha, Ariela, Fedrigo, Marny, Simioni, Paolo

“…IgG anti-Domain I (anti-DI) β2 Glycoprotein I (β2GPI) antibodies are associated to thrombotic risk in antiphospholipid syndrome (APS), but their detection is…”
Get full text

The impact of SARS-CoV-2 infection and vaccination on inflammatory arthritis: a cohort study by Striani, Giovanni, Hoxha, Ariela, Lorenzin, Mariagrazia, Cozzi, Giacomo, Scagnellato, Laura, Vangelista, Tatiana, Frizzera, Francesca, De Sandre, Pierino, Simioni, Paolo, Doria, Andrea, Ramonda, Roberta

“…To investigate the effects of SARS-CoV-2 infection, as well as short- (within 48 hours) and long-term (within 30 days) adverse events (AEs) of SARS-CoV-2…”
Get full text

Therapeutic apheresis during pregnancy: A single center experience by Colpo, Anna, Marson, Piero, Pavanello, Francesca, Tison, Tiziana, Gervasi, Maria Teresa, Zambon, Alessandra, Ruffatti, Amelia, De Silvestro, Giustina, Hoxha, Ariela

“…Therapeutic apheresis (TA) represents a treatment option for pre-existing conditions or diseases occurring during gestation. Although pregnancy is not a…”
Get full text

Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome by Hoxha, Ariela, Ruffatti, Amelia, Mattia, Elena, Meneghel, Lauro, Tonello, Marta, Salvan, Elisa, Pengo, Vittorio, Punzi, Leonardo

“…Antiphosphatidylserine/prothrombin complex (aPS/PT) antibodies are emerging as an important marker for antiphospholipid syndrome (APS). We aimed to compare…”
Get more information

Obstetrical outcome and treatments in seronegative primary APS: data from European retrospective study by Abisror, Noemie, Nguyen, Yann, Marozio, Luca, Esteve Valverde, Enrique, Udry, Sebastian, Pleguezuelo, Daniel Enrique, Billoir, Paul, Mayer-Pickel, Karoline, Urbanski, Geoffrey, Zigon, Polona, De Moreuil, Claire, Hoxha, Ariela, Bezanahary, Holy, Carbillon, Lionel, Kayem, Gilles, Bornes, Marie, Yelnik, Cecile, Johanet, Cathererine, Nicaise-Roland, Pascale, Lambert, Marc, Salle, Valéry, Latino, Omar Jose, Hachulla, Eric, Benedetto, Chiara, Bourrienne, Marie Charlotte, Benhamou, Ygal, Alijotas-Reig, Jaume, Fain, Olivier, Mekinian, Arsène

“…ObjectiveTo compare characteristics, pregnancies and treatments during pregnancies of seronegative and seropositive antiphospholipid syndrome (APS), to analyse…”
Get full text

Maternal autoantibody profiles at risk for autoimmune congenital heart block: a prospective study in high-risk patients by Tonello, Marta, Ruffatti, Amelia, Favaro, Maria, Tison, Tiziana, del Ross, Teresa, Calligaro, Antonia, Hoxha, Ariela, Mattia, Elena, Punzi, Leonardo

“…ObjectiveThis prospective study aimed to identify antibody profiles characterising mothers with fetuses developing congenital heart block (CHB) by comparing…”
Get full text

Detection of Lupus Anticoagulant in the era of Direct Oral Anticoagulants by Hoxha, Ariela, Banzato, Alessandra, Ruffatti, Amelia, Pengo, Vittorio

“…Abstract Lupus anticoagulant (LAC) is an in vitro phenomenon determining a phospholipid-dependent elongation of clotting times. The presence of LAC associated…”
Get full text

Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome by Pengo, Vittorio, Denas, Gentian, Zoppellaro, Giacomo, Jose, Seena Padayattil, Hoxha, Ariela, Ruffatti, Amelia, Andreoli, Laura, Tincani, Angela, Cenci, Caterina, Prisco, Domenico, Fierro, Tiziana, Gresele, Paolo, Cafolla, Arturo, De Micheli, Valeria, Ghirarduzzi, Angelo, Tosetto, Alberto, Falanga, Anna, Martinelli, Ida, Testa, Sophie, Barcellona, Doris, Gerosa, Maria, Banzato, Alessandra

“…Rivaroxaban is an effective and safe alternative to warfarin in patients with atrial fibrillation and venous thromboembolism. We tested the efficacy and safety…”
Get full text

Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two‐year outcomes after the study closure by Pengo, Vittorio, Hoxha, Ariela, Andreoli, Laura, Tincani, Angela, Silvestri, Elena, Prisco, Domenico, Fierro, Tiziana, Gresele, Paolo, Cafolla, Arturo, De Micheli, Valeria, Ghirarduzzi, Angelo, Tosetto, Alberto, Falanga, Anna, Martinelli, Ida, Testa, Sophie, Barcellona, Doris, Gerosa, Maria, Denas, Gentian

“…Background Trial of Rivaroxaban in AntiPhospholipid Syndrome was a prospective randomized, open‐label, noninferiority study conducted in 14 centers in Italy…”
Get full text

Risk factors for damage accrual in primary antiphospholipid syndrome: A retrospective single-center cohort study by Hoxha, Ariela, Perin, Nicola, Lovisotto, Marco, Calligaro, Antonia, Del Ross, Teresa, Favaro, Maria, Tonello, Marta, Doria, Andrea, Simioni, Paolo

“…Despite anticoagulant therapy, a antiphospholipid syndrome (APS) has a higher rate of recurrent events, which can lead to damage accrual and a negative impact…”
Get full text

IgG phosphatidylserine/prothrombin antibodies as a risk factor of thrombosis in antiphospholipid antibody carriers by Tonello, Marta, Mattia, Elena, Favaro, Maria, Del Ross, Teresa, Calligaro, Antonia, Salvan, Elisa, Hoxha, Ariela, Fedrigo, Marny, Ruffatti, Amelia

“…The clinical significance of IgG/IgM antiphosphatidylserine/prothrombin (aPS/PT) antibodies was prospectively evaluated in a cohort of 191 antiphospholipid…”
Get full text

Prevalence and adverse consequences of delayed diagnosis and misdiagnosis in thrombotic antiphospholipid syndrome. An observational cohort study and a review of the literature by Ruffatti, Amelia, Tonello, Marta, Calligaro, Antonia, Del Ross, Teresa, Favaro, Maria, Zen, Margherita, Hoxha, Ariela, Alaibac, Mauro

“…Obiectives This study aims to prospectively evaluate the frequency and adverse consequences of diagnostic delay and misdiagnosis in a cohort of patients with…”
Get full text

Anti-phospholipid antibodies nephropathy is associated with an increased risk of kidney failure: a systematic literature review and meta-analysis by Hoxha, Ariela, Lovisotto, Marco, Perin, Nicola, Nalesso, Federico, Del Prete, Dorella, Simioni, Paolo

“…Background Anti-phospholipid antibodies nephropathy (aPL-N) is a complex feature of anti-phospholipid syndrome due to microvascular lesions. Renal prognosis…”
Get full text

Markers of complement activation in plasma during quiescent phases in patients with catastrophic antiphospholipid syndrome by Ruffatti, Amelia, Tonello, Marta, Macor, Paolo, Calligaro, Antonia, Del Ross, Teresa, Favaro, Maria, Lotti, Virginia, Carletto, Antonio, Hoxha, Ariela, Biasi, Domenico

“…Accumulating evidence suggests that complement activation is a critical contributor to catastrophic antiphospholipid syndrome (CAPS). While complement…”
Get full text

Impact of COVID-19 and COVID-19 vaccination on high-risk patients with antiphospholipid syndrome: a nationwide survey by Pengo, Vittorio, Del Ross, Teresa, Tonello, Marta, Andreoli, Laura, Tincani, Angela, Gresele, Paolo, Silvestri, Elena, Simioni, Paolo, Campello, Elena, Hoxha, Ariela, Falanga, Anna, Ghirarduzzi, Angelo, Denas, Gentian

“…Abstract Objectives Patients with APS and triple-positive for aPL are at high risk of recurrent events. As COVID-19 and COVID-19 vaccination may induce…”
Get full text